Boberg M - Search Results

1

Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human Liver.

Bhatt DK, Mehrotra A, Gaedigk A, Chapa R, Basit A, Zhang H, Choudhari P, Boberg M, Pearce RE, Gaedigk R, Broeckel U, Leeder JS, Prasad B. Bhatt DK, et al. Among authors: boberg m. Clin Pharmacol Ther. 2019 Jan;105(1):131-141. doi: 10.1002/cpt.1109. Epub 2018 Jul 12. Clin Pharmacol Ther. 2019. PMID: 29737521 Free PMC article.

2

Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.

Boberg M, Vrana M, Mehrotra A, Pearce RE, Gaedigk A, Bhatt DK, Leeder JS, Prasad B. Boberg M, et al. Drug Metab Dispos. 2017 Feb;45(2):216-223. doi: 10.1124/dmd.116.072652. Epub 2016 Nov 28. Drug Metab Dispos. 2017. PMID: 27895113 Free PMC article.

3

Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.

Rettie AE, Boberg M, Rettenmeier AW, Baillie TA. Rettie AE, et al. Among authors: boberg m. J Biol Chem. 1988 Sep 25;263(27):13733-8. J Biol Chem. 1988. PMID: 3138238 Free article.

4

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.

Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M. Boberg M, et al. Drug Metab Dispos. 1997 Mar;25(3):321-31. Drug Metab Dispos. 1997. PMID: 9172950

5

Biotransformation of cerivastatin in mice, rats, and dogs in vivo.

Boberg M, Angerbauer R, Kanhai WK, Karl W, Kern A, Radtke M, Steinke W. Boberg M, et al. Drug Metab Dispos. 1998 Jul;26(7):640-52. Drug Metab Dispos. 1998. PMID: 9660846

6

Preclinical review of cerivastatin sodium--a step forward in HMG-CoA reductase inhibition.

Bischoff H, Angerbauer R, Boberg M, Petzinna D, Schmidt D, Steinke W, Thomas G. Bischoff H, et al. Among authors: boberg m. Atherosclerosis. 1998 Sep;139 Suppl 1:S7-13. doi: 10.1016/s0021-9150(98)00188-9. Atherosclerosis. 1998. PMID: 9811153 Review.

7

Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.

Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Ahr HJ, et al. Among authors: boberg m. Arzneimittelforschung. 1997 Jun;47(6):734-45. Arzneimittelforschung. 1997. PMID: 9239452 Clinical Trial.

8

Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.

Boberg M, Ahr HJ, Beckermann B, Bühner K, Siefert HM, Steinke W, Wünsche C, Hirayama M. Boberg M, et al. Arzneimittelforschung. 1997 Aug;47(8):928-38. Arzneimittelforschung. 1997. PMID: 9296279

9

Isolation and structural elucidation of biotransformation products from acarbose.

Boberg M, Kurz J, Ploschke HJ, Schmitt P, Scholl H, Schüller M, Wünsche C. Boberg M, et al. Arzneimittelforschung. 1990 May;40(5):555-63. Arzneimittelforschung. 1990. PMID: 2383295

10

Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man.

Ahr HJ, Boberg M, Krause HP, Maul W, Müller FO, Ploschke HJ, Weber H, Wünsche C. Ahr HJ, et al. Among authors: boberg m. Arzneimittelforschung. 1989 Oct;39(10):1254-60. Arzneimittelforschung. 1989. PMID: 2610717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters